Blood collection devices market worth $7.8 billion by 2026
Chicago, July 14 2022 (GLOBE NEWSWIRE) — According to the new market research report “Blood Collection Devices Market by product (tubes (plasma (EDTA, heparin), serum), needles and syringes, blood bags, monitors), method (manual, automated), application (diagnostic, therapeutic), end user (hospitals, blood banks) – Global forecast to 2026″is expected to reach USD 7.8 billion by 2026 from USD 5.7 billion in 2021, at a CAGR of 6.0% during the forecast period.
Browse and deepen the table of contents on “Blood Collection Devices Market“
374 – Tables
50 – Numbers
335 – pages
Download the PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=39733117
Key growth factors for this market include increasing incidence of infectious diseases, increasing number of accidents and trauma cases, emergence of liquid biopsy tests, and demand for blood and blood component donations. However, the complexities of storage and shipping and the lack of skilled professionals are hindering the growth of this market.
Based on product, the global blood collection devices market is segmented into needles and syringes, blood collection tubes, blood bags, systems/monitors, and lancets. The blood collection tubes segment is expected to register the highest growth rate during the forecast period. The growth of this market segment is driven by the increasing prevalence of blood disorders, increasing demand for plasma from biopharmaceutical companies for plasma fractionation and increasing demand for apheresis and whole blood collection devices from blood banks in the emerging countries.
Request sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=39733117
Based on the method, the global blood collection devices market is segmented into manual and automated blood collection. The manual blood collection segment is expected to dominate the global market. However, the automated blood collection segment is expected to register a higher CAGR during the forecast period. The growth of the automated blood collection segment can be attributed to the increasing demand for safer procedures and the availability of advanced blood collection products.
Based on application, the global blood collection devices market is segmented into diagnostics and therapeutics. The diagnostics segment is expected to dominate the market over the forecast period. This is attributed to factors such as the growing prevalence of chronic diseases. This segment is also expected to witness the highest CAGR owing to the growing awareness of regular health checkups.
Talk to the analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=39733117
Geographic growth scenario:
The global blood collection devices market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. North America (consisting of the United States and Canada) is expected to account for the largest share of the global market in 2021, followed by Europe. Factors such as growing prevalence of lifestyle diseases and increasing incidence of blood disorders, better healthcare facilities and presence of major manufacturers in the region are driving the growth of the blood collection devices market in North America. North.
Major Players of the Blood Collection Devices Market:
- Becton, Dickinson and Company (USA),
- Terumo BCT (USA),
- Fresenius Kabi AG (Germany),
- Grifols, SA (Spain),
- Nipro Medical Corporation (Japan),
- Quest Diagnostics (USA),
- SARSTEDT AG (Germany),
- Haemonetics Corporation (USA),
- Greiner Holding AG (Austria), and
- Smiths Medical (USA).
Browse adjacent markets: Study reports and advice on the medical device market
Browse related reports:
Medical supplies market by Type (Diagnostics, Dialysis, Wound Care, Disinfectants, PPE, Radiology, Sterilization, Catheters), Application (Urology, Cardiology, Infection Control), End User (Hospitals, Clinics and Doctor’s Offices) – Global Forecast to 2025
Lancet Market by Type (Safety Lancets (Push Button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Test, Hemoglobin Test), End User (Hospital, Clinic, Home Care), Region – Forecast world until 2024